Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

HC Wainwright & Co. Reiterates Buy on Kala Pharmaceuticals, Raises Price Target to $24

Author: Benzinga Newsdesk | May 10, 2023 06:44am

HC Wainwright & Co. analyst Yi Chen reiterates Kala Pharmaceuticals (NASDAQ:KALA) with a Buy and raises the price target from $22 to $24.

Posted In: KALA